We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




ResMed Finalizes Purchase of Inova Labs

By HospiMedica International staff writers
Posted on 14 Feb 2016
Print article
Image: The LifeChoice Activox portable oxygen concentrator (Photo courtesy of ResMed).
Image: The LifeChoice Activox portable oxygen concentrator (Photo courtesy of ResMed).
Respiratory device manufacturer ResMed (San Diego, CA, USA) has completed the acquisition Inova Labs (Austin, TX, USA), a developer of oxygen therapy products. Financial terms were not disclosed.

The deal will allow ResMed to expand its respiratory care offerings and solutions for people with chronic obstructive pulmonary disease (COPD), which currently include products such as the AirCurve 10 series of cloud-connected noninvasive ventilators, the Stellar series of noninvasive ventilators, and the Astral lightweight noninvasive life-support platform with internal and external batteries that provide up to 24 hours of freedom for patients.

The acquisition will add both portable oxygen concentrators and necessary stationary options for the home to the ResMed portfolio, which include the LifeChoice Activox, a lightweight and portable oxygen concentrator that provides enhanced battery life for greater freedom and mobility, and the Activox DUO2, a fully integrated stationary and portable oxygen concentrator system. Oxygen therapy is the largest non-drug delivery medical device segment for the treatment of COPD.

“With the acquisition of Inova Labs, ResMed is delivering on its commitment to find further ways to improve the quality of life for tens of millions of people as they deal with COPD, this chronic, progressive disease that literally takes patients’ breath away when untreated,” said Mick Farrell, CEO of ResMed. “We are excited to expand our offerings and solutions for the global COPD epidemic and to progress even more swiftly toward our ResMed goal of improving 20 million lives by 2020.”

“ResMed is the global leader in connected healthcare solutions for sleep and respiratory conditions. That’s a perfect fit with our mission to offer oxygen therapy solutions that empower individuals to stay active and sleep well,” said John Rush, CEO of Inova Labs. “We are excited about joining forces with ResMed and benefiting from their global expertise and innovative culture, to improve patient engagement and adherence to treatment, to create business efficiencies for home medical equipment providers, and to help enhance the quality of life for those suffering from COPD and other chronic respiratory conditions.”

COPD is the co-occurrence of chronic bronchitis and emphysema, a pair of commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs, causing shortness of breath (dyspnea). In clinical practice, COPD is defined by its characteristically low airflow on lung function tests. In contrast to asthma, this limitation is poorly reversible and usually gets progressively worse over time. Worldwide, COPD ranked as the sixth leading cause of death in 1990, and is projected to be the fourth leading cause of death worldwide by 2030, due to an increase in smoking rates and demographic changes in many countries.

Related Links:

ResMed
Inova Labs


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Single Cavity Combination Warmer
EC550BL

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.